Evidence map›Paper›PMID 31363131›Full record

ArticleScientific reports2019

5-hydroxymethylcytosine Marks Mammalian Origins Acting as a Barrier to Replication.

Terezia Prikrylova, Julia Robertson, Francesca Ferrucci, Dorota Konorska, Håvard Aanes, Adeel Manaf, Beibei Zhang, Cathrine Broberg Vågbø, Anna Kuśnierczyk, Karin M Gilljam and 6 more

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. 5-Hydroxymethylcytosine: Far Beyond the Intermediate of DNA Demethylation.International journal of molecular sciences · 2024
    Review
  6. Article
  7. Genome-wide 5-hydroxymethylcytosines in circulating cell-free DNA as noninvasive diagnostic markers for gastric cancer.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Terezia PrikrylovaInstitute of Medical Microbiology, Oslo University Hospital, Rikshospitalet, Norway.
Julia RobertsonInstitute of Medical Microbiology, Oslo University Hospital, Rikshospitalet, Norway.
Francesca FerrucciInstitute of Medical Microbiology, Oslo University Hospital, Rikshospitalet, Norway.
Dorota KonorskaInstitute of Medical Microbiology, Oslo University Hospital, Rikshospitalet, Norway.
Håvard AanesInstitute of Medical Microbiology, Oslo University Hospital, Rikshospitalet, Norway.
Adeel ManafInstitute of Medical Microbiology, Oslo University Hospital, Rikshospitalet, Norway.
Beibei ZhangDepartment of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, 0379, Oslo, Norway.
Cathrine Broberg VågbøProteomics and Metabolomics Core Facility, Norwegian University of Science and Technology, 7491, Trondheim, Norway.
Anna KuśnierczykProteomics and Metabolomics Core Facility, Norwegian University of Science and Technology, 7491, Trondheim, Norway.
Karin M GilljamInstitute of Medical Microbiology, Oslo University Hospital, Rikshospitalet, Norway.
Caroline Løvkvam-KøsterInstitute of Medical Microbiology, Oslo University Hospital, Rikshospitalet, Norway.
Marit OtterleiInstitute of Medical Microbiology, Oslo University Hospital, Rikshospitalet, Norway.
John Arne DahlInstitute of Medical Microbiology, Oslo University Hospital, Rikshospitalet, Norway.
Jorrit EnserinkDepartment of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, 0379, Oslo, Norway.
Arne KlunglandInstitute of Medical Microbiology, Oslo University Hospital, Rikshospitalet, Norway.
Adam B RobertsonInstitute of Medical Microbiology, Oslo University Hospital, Rikshospitalet, Norway. adam.robertson@hemispherian.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In most mammalian cells, DNA replication occurs once, and only once between cell divisions. Replication initiation is a highly regulated process with redundant mechanisms that prevent errant initiation events. In lower eukaryotes, replication is initiated from a defined consensus sequence, whereas a consensus sequence delineating mammalian origin of replication has not been identified. Here we show that 5-hydroxymethylcytosine (5hmC) is present at mammalian replication origins. Our data support the hypothesis that 5hmC has a role in cell cycle regulation. We show that 5hmC level is inversely proportional to proliferation; indeed, 5hmC negatively influences cell division by increasing the time a cell resides in G1. Our data suggest that 5hmC recruits replication-licensing factors, then is removed prior to or during origin firing. Later we propose that TET2, the enzyme catalyzing 5mC to 5hmC conversion, acts as barrier to rereplication. In a broader context, our results significantly advance the understating of 5hmC involvement in cell proliferation and disease states.

Indexed as

5-MethylcytosineCell CycleCell DivisionCell ProliferationDNA ReplicationHeLa CellsHumansReplication Origin5-hydroxymethylcytosine5-Methylcytosine

Identifiers

PMID31363131
PMCPMC6667497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.